Moriarty John B 4
4 · Mirati Therapeutics, Inc. · Filed Aug 10, 2023
Insider Transaction Report
Form 4
Moriarty John B
Chief Legal Officer
Transactions
- Award
Common Stock
2023-08-09$37.00/sh+22,297$824,989→ 71,660 total
Footnotes (1)
- [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the one year anniversary of the grant date.